vs

Side-by-side financial comparison of AerSale Corp (ASLE) and Core Laboratories Inc. (CLB). Click either name above to swap in a different company.

Core Laboratories Inc. is the larger business by last-quarter revenue ($121.8M vs $90.9M, roughly 1.3× AerSale Corp). AerSale Corp runs the higher net margin — 5.9% vs 4.2%, a 1.7% gap on every dollar of revenue. On growth, Core Laboratories Inc. posted the faster year-over-year revenue change (-1.4% vs -4.0%). AerSale Corp produced more free cash flow last quarter ($9.8M vs $517.0K). Over the past eight quarters, AerSale Corp's revenue compounded faster (0.2% CAGR vs -3.4%).

AerSale, Inc. is a Doral, Florida-based global supplier of aftermarket commercial jet aircraft, engines, used materials, and aeronautical engineering services to passenger and cargo airlines, government, multinational original equipment manufacturers, and independent MROs. AerSale is a member of the Aircraft Fleet Recycling Association.

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

ASLE vs CLB — Head-to-Head

Bigger by revenue
CLB
CLB
1.3× larger
CLB
$121.8M
$90.9M
ASLE
Growing faster (revenue YoY)
CLB
CLB
+2.6% gap
CLB
-1.4%
-4.0%
ASLE
Higher net margin
ASLE
ASLE
1.7% more per $
ASLE
5.9%
4.2%
CLB
More free cash flow
ASLE
ASLE
$9.3M more FCF
ASLE
$9.8M
$517.0K
CLB
Faster 2-yr revenue CAGR
ASLE
ASLE
Annualised
ASLE
0.2%
-3.4%
CLB

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ASLE
ASLE
CLB
CLB
Revenue
$90.9M
$121.8M
Net Profit
$5.4M
$5.1M
Gross Margin
34.1%
Operating Margin
7.8%
1.5%
Net Margin
5.9%
4.2%
Revenue YoY
-4.0%
-1.4%
Net Profit YoY
99.7%
EPS (diluted)
$0.10
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASLE
ASLE
CLB
CLB
Q1 26
$121.8M
Q4 25
$90.9M
$138.3M
Q3 25
$71.2M
$134.5M
Q2 25
$107.4M
$130.2M
Q1 25
$65.8M
$123.6M
Q4 24
$94.7M
$129.2M
Q3 24
$82.7M
$134.4M
Q2 24
$77.1M
$130.6M
Net Profit
ASLE
ASLE
CLB
CLB
Q1 26
$5.1M
Q4 25
$5.4M
$4.9M
Q3 25
$-120.0K
$14.2M
Q2 25
$8.6M
$10.6M
Q1 25
$-5.3M
$-154.0K
Q4 24
$2.7M
$7.4M
Q3 24
$509.0K
$11.7M
Q2 24
$-3.6M
$9.0M
Gross Margin
ASLE
ASLE
CLB
CLB
Q1 26
Q4 25
34.1%
20.8%
Q3 25
30.2%
22.0%
Q2 25
32.9%
20.3%
Q1 25
27.3%
19.5%
Q4 24
31.4%
17.8%
Q3 24
28.6%
20.5%
Q2 24
28.2%
21.2%
Operating Margin
ASLE
ASLE
CLB
CLB
Q1 26
1.5%
Q4 25
7.8%
11.5%
Q3 25
4.0%
15.6%
Q2 25
11.7%
11.7%
Q1 25
-10.1%
3.6%
Q4 24
5.2%
11.0%
Q3 24
2.4%
14.7%
Q2 24
-2.4%
12.3%
Net Margin
ASLE
ASLE
CLB
CLB
Q1 26
4.2%
Q4 25
5.9%
3.6%
Q3 25
-0.2%
10.6%
Q2 25
8.0%
8.2%
Q1 25
-8.0%
-0.1%
Q4 24
2.9%
5.7%
Q3 24
0.6%
8.7%
Q2 24
-4.7%
6.9%
EPS (diluted)
ASLE
ASLE
CLB
CLB
Q1 26
$0.11
Q4 25
$0.10
$0.11
Q3 25
$0.00
$0.30
Q2 25
$0.18
$0.22
Q1 25
$-0.10
$0.00
Q4 24
$0.05
$0.15
Q3 24
$0.01
$0.25
Q2 24
$-0.07
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASLE
ASLE
CLB
CLB
Cash + ST InvestmentsLiquidity on hand
$4.4M
$22.8M
Total DebtLower is stronger
$1.3M
Stockholders' EquityBook value
$424.4M
$275.1M
Total Assets
$640.5M
$587.7M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASLE
ASLE
CLB
CLB
Q1 26
$22.8M
Q4 25
$4.4M
$22.7M
Q3 25
$5.3M
$25.6M
Q2 25
$5.7M
$31.2M
Q1 25
$4.7M
$22.1M
Q4 24
$4.7M
$19.2M
Q3 24
$9.8M
$21.5M
Q2 24
$4.3M
$17.7M
Total Debt
ASLE
ASLE
CLB
CLB
Q1 26
Q4 25
$1.3M
$110.3M
Q3 25
$1.5M
$114.1M
Q2 25
$907.0K
$124.6M
Q1 25
$1.1M
$124.4M
Q4 24
$1.2M
$126.1M
Q3 24
$376.0K
$139.9M
Q2 24
$522.0K
$147.6M
Stockholders' Equity
ASLE
ASLE
CLB
CLB
Q1 26
$275.1M
Q4 25
$424.4M
$266.0M
Q3 25
$417.1M
$271.3M
Q2 25
$415.9M
$261.3M
Q1 25
$406.5M
$253.4M
Q4 24
$455.6M
$246.6M
Q3 24
$451.5M
$250.7M
Q2 24
$449.8M
$240.3M
Total Assets
ASLE
ASLE
CLB
CLB
Q1 26
$587.7M
Q4 25
$640.5M
$584.0M
Q3 25
$646.3M
$591.4M
Q2 25
$646.7M
$602.1M
Q1 25
$646.1M
$591.5M
Q4 24
$604.7M
$585.1M
Q3 24
$601.5M
$600.5M
Q2 24
$598.7M
$597.8M
Debt / Equity
ASLE
ASLE
CLB
CLB
Q1 26
Q4 25
0.00×
0.41×
Q3 25
0.00×
0.42×
Q2 25
0.00×
0.48×
Q1 25
0.00×
0.49×
Q4 24
0.00×
0.51×
Q3 24
0.00×
0.56×
Q2 24
0.00×
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASLE
ASLE
CLB
CLB
Operating Cash FlowLast quarter
$11.4M
$4.0M
Free Cash FlowOCF − Capex
$9.8M
$517.0K
FCF MarginFCF / Revenue
10.8%
0.4%
Capex IntensityCapex / Revenue
1.7%
Cash ConversionOCF / Net Profit
2.11×
0.77×
TTM Free Cash FlowTrailing 4 quarters
$-29.1M
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASLE
ASLE
CLB
CLB
Q1 26
$4.0M
Q4 25
$11.4M
$7.9M
Q3 25
$-8.9M
$8.5M
Q2 25
$19.8M
$13.9M
Q1 25
$-45.2M
$6.7M
Q4 24
$37.5M
$20.6M
Q3 24
$10.4M
$13.1M
Q2 24
$-15.3M
$17.1M
Free Cash Flow
ASLE
ASLE
CLB
CLB
Q1 26
$517.0K
Q4 25
$9.8M
$5.0M
Q3 25
$-9.8M
$6.5M
Q2 25
$18.6M
$10.4M
Q1 25
$-47.6M
$3.9M
Q4 24
$32.3M
$17.4M
Q3 24
$8.9M
$10.4M
Q2 24
$-18.9M
$14.3M
FCF Margin
ASLE
ASLE
CLB
CLB
Q1 26
0.4%
Q4 25
10.8%
3.6%
Q3 25
-13.8%
4.8%
Q2 25
17.3%
8.0%
Q1 25
-72.4%
3.1%
Q4 24
34.0%
13.4%
Q3 24
10.7%
7.7%
Q2 24
-24.6%
10.9%
Capex Intensity
ASLE
ASLE
CLB
CLB
Q1 26
Q4 25
1.7%
2.1%
Q3 25
1.3%
1.5%
Q2 25
1.1%
2.7%
Q1 25
3.7%
2.3%
Q4 24
5.6%
2.5%
Q3 24
1.9%
2.0%
Q2 24
4.7%
2.2%
Cash Conversion
ASLE
ASLE
CLB
CLB
Q1 26
0.77×
Q4 25
2.11×
1.61×
Q3 25
0.60×
Q2 25
2.31×
1.31×
Q1 25
Q4 24
13.89×
2.78×
Q3 24
20.52×
1.12×
Q2 24
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASLE
ASLE

Products$57.8M64%
Maintenance$23.2M26%
Leasing Arrangements$9.9M11%

CLB
CLB

Segment breakdown not available.

Related Comparisons